Document Detail

Effective treatment of female androgenic alopecia with dutasteride.
MedLine Citation:
PMID:  16167423     Owner:  NLM     Status:  MEDLINE    
Dihydrotestosterone is the main molecule responsible for androgenic alopecia. Finasteride, which reduces transformation of testosterone into dihydrotestosterone and decreases dihydrotestosterone activity, is approved for treatment of androgenic alopecia in men. We describe the case of a 46-year-old woman with androgenic alopecia, non-responsive to minoxidil, who initially benefited from finasteride. Due to only limited improvement after finasteride and persisting profound psychological distress resulting from androgenic alopecia, another 5-reductase inhibitor, dutasteride, was introduced. Clinical evaluation and trichogram were applied for assessment of dutasteride efficacy in this patient. Additionally, mean hair diameter was monitored by means of computer dermoscopy. After 6 months of therapy, significant improvement was observed and after 9 months the clinical diagnosis of androgenic alopecia could no longer be made in this patient. No side effects were observed. In conclusion, theoretical data and our experience in this case show that dutasteride might develop into a true alternative in treatment of androgenic alopecia.
Malgorzata Olszewska; Lidia Rudnicka
Related Documents :
8300463 - Neurocysticercosis.
11941123 - Optimizing unilateral electroconvulsive therapy.
19326693 - Atrophoderma vermiculatum: a case report and review of the literature on keratosis pila...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Journal of drugs in dermatology : JDD     Volume:  4     ISSN:  1545-9616     ISO Abbreviation:  J Drugs Dermatol     Publication Date:    2005 Sep-Oct
Date Detail:
Created Date:  2005-09-19     Completed Date:  2005-10-26     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101160020     Medline TA:  J Drugs Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  637-40     Citation Subset:  IM    
Department of Dermatology, Warsaw Medical School, Warsaw, Poland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alopecia / drug therapy*,  pathology
Azasteroids / adverse effects,  therapeutic use*
Enzyme Inhibitors / adverse effects,  therapeutic use*
Finasteride / therapeutic use
Middle Aged
Minoxidil / therapeutic use
Scalp / pathology
Skin / pathology
Testosterone 5-alpha-Reductase / antagonists & inhibitors*
Reg. No./Substance:
0/Azasteroids; 0/Enzyme Inhibitors; 0/dutasteride; 38304-91-5/Minoxidil; 98319-26-7/Finasteride; EC 5-alpha-Reductase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Punctate palmoplantar keratoderma (Buschke-Fischer-Brauer disease) with psoriasis: a rare associatio...
Next Document:  Cutaneous leiomyomatosis and parotid pleomorphic adenoma.